Performance of propofol target-controlled infusion models in the obese: Pharmacokinetic and pharmacodynamic analysis

Anesthesia and Analgesia

Volumn 119, Issue 2, 2014, Pages 302-310

  Cortínez, Luis I ^a   De La Fuente, Natalia ^a   Eleveld, Douglas J ^b   Oliveros, Ana ^a   Crovari, Fernando ^a   Sepulveda, Pablo ^c   Ibacache, Mauricio ^a   Solari, Sandra ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; PHENYLEPHRINE; PROPOFOL; REMIFENTANIL; ROCURONIUM;

ADULT; ALLOMETRY; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTICLE; BARIATRIC SURGERY; BISPECTRAL INDEX; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG INFUSION; FAT FREE MASS; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LEAN BODY WEIGHT; LIMIT OF DETECTION; MALE; OBESITY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL;

ADULT; ANESTHETICS, INTRAVENOUS; BARIATRIC SURGERY; BODY MASS INDEX; BODY WEIGHT; CONSCIOUSNESS; CONSCIOUSNESS MONITORS; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LAPAROSCOPY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MONITORING, INTRAOPERATIVE; NARCOTIC ANTAGONISTS; OBESITY, MORBID; PIPERIDINES; PREDICTIVE VALUE OF TESTS; PROPOFOL; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84904755880     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000317     Document Type: Article

References (45)

1. Struys MM, De Smet T, Depoorter B, Versichelen LF, Mortier EP, Dumortier FJ, Shafer SL, Rolly G. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 2000;92:399-406
2. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000;39:215-31
3. De Baerdemaeker L, Mortier E, Struys M. Pharmacokinetics in obese patients. Continuing education in anaesthesia. Crit Care Pain 2004;4:152-5
4. Wani S, Azar R, Hovis CE, Hovis RM, Cote GA, Hall M, Waldbaum L, Kushnir V, Early D, Mullady DK, Murad F, Edmundowicz SA, Jonnalagadda SS. Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. Gastrointest Endosc 2011;74:1238-47
5. La Colla L, Albertin A, La Colla G, Ceriani V, Lodi T, Porta A, Aldegheri G, Mangano A, Khairallah I, Fermo I. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. Eur J Anaesthesiol 2009;26:362-9
6. Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol-defining and illuminating the devil in the detail. Br J Anaesth 2009;103:26-37
7. Cortínez LI, Anderson BJ, Penna A, Olivares L, Muñoz HR, Holford NH, Struys MM, Sepulveda P. Influence of obesity on propofol pharmacokinetics: Derivation of a pharmacokinetic model. Br J Anaesth 2010;105:448-56
8. van Kralingen S, Diepstraten J, Peeters MY, Deneer VH, van Ramshorst B, Wiezer RJ, van Dongen EP, Danhof M, Knibbe CA. Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients. Clin Pharmacokinet 2011;50:739-50
9. Eleveld DJ, Proost JH, Cortínez LI, Absalom AR, Struys MM. A general purpose pharmacokinetic model for propofol. Anesth Analg 2014;118:1221-37
10. Marsh B,White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991;67:41-8
11. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88:1170-82
12. Seno H, He YL, Tashiro C, Ueyama H, Mashimo T. Simple high-performance liquid chromatographic assay of propofol in human and rat plasma and various rat tissues. J Anesth 2002;16:87-9
13. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992;20:63-94
14. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharmacol Ther 1979;25:358-71
15. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet 2005;44:1051-65
16. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004;58:119-33
17. Schüttler J, Kloos S, Schwilden H, Stoeckel H. Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion. Anaesthesia 1988;43 Suppl:2-7
18. Glass PSA, Shafer SL, Reves JG. Intravenous drug delivery systems. In: Miller RD, ed. Miller's Anesthesia. Philadelphia, PA: Elsevier (Churchill Livinstone), 2005:439-80
19. Doufas AG, Bakhshandeh M, Bjorksten AR, Shafer SL, Sessler DI. Induction speed is not a determinant of propofol pharmacodynamics. Anesthesiology 2004;101:1112-21
20. Rigouzzo A, Girault L, Louvet N, Servin F, De-Smet T, Piat V, Seeman R, Murat I, Constant I. The relationship between bispectral index and propofol during target-controlled infusion anesthesia: A comparative study between children and young adults. Anesth Analg 2008;106:1109-16
21. Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 1993;78:657-65
22. Albertin A, Poli D, La Colla L, Gonfalini M, Turi S, Pasculli N, La Colla G, Bergonzi PC, Dedola E, Fermo I. Predictive performance of 'servin's formula? during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients. Br J Anaesth 2007;98:66-75
23. Coates DP, Monk CR, Prys-Roberts C, Turtle M. Hemodynamic effects of infusions of the emulsion formulation of propofol during nitrous oxide anesthesia in humans. Anesth Analg 1987;66:64-70
24. Mertens MJ, Olofsen E, Burm AG, Bovill JG, Vuyk J. Mixedeffects modeling of the influence of alfentanil on propofol pharmacokinetics. Anesthesiology 2004;100:795-805
25. Wietasch JK, Scholz M, Zinserling J, Kiefer N, Frenkel C, Knüfermann P, Brauer U, Hoeft A. The performance of a targetcontrolled infusion of propofol in combination with remifentanil: A clinical investigation with two propofol formulations. Anesth Analg 2006;102:430-7
26. Yufune S, Takamatsu I, Masui K, Kazama T. Effect of remifentanil on plasma propofol concentration and bispectral index during propofol anaesthesia. Br J Anaesth 2011;106:208-14
27. Bouillon T, Bruhn J, Radu-Radulescu L, Bertaccini E, Park S, Shafer S. Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil. Anesthesiology 2002;97:1350-62
28. Gutt CN, Oniu T, Mehrabi A, Schemmer P, Kashfi A, Kraus T, Büchler MW. Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg 2004;21:95-105
29. Nguyen NT, Ho HS, Fleming NW, Moore P, Lee SJ, Goldman CD, Cole CJ, Wolfe BM. Cardiac function during laparoscopic vs open gastric bypass. Surg Endosc 2002;16:78-83
30. Perilli V, Sollazzi L, Modesti C, Annetta MG, Sacco T, Bocci MG, Tacchino RM, Proietti R. Comparison of positive endexpiratory pressure with reverse Trendelenburg position in morbidly obese patients undergoing bariatric surgery: Effects on hemodynamics and pulmonary gas exchange. Obes Surg 2003;13:605-9
31. Bauer LA, Edwards WA, Dellinger EP, Simonowitz DA. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol 1983;24:643-7
32. La Colla L, Albertin A, La Colla G, Porta A, Aldegheri G, Di Candia D, Gigli F. Predictive performance of the 'Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass. Clin Pharmacokinet 2010;49:131-9
33. Coetzee JF. Allometric or lean body mass scaling of propofol pharmacokinetics: Towards simplifying parameter sets for target-controlled infusions. Clin Pharmacokinet 2012;51:137-45
34. Struys MM, Coppens MJ, De Neve N, Mortier EP, Doufas AG, Van Bocxlaer JF, Shafer SL. Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology 2007;107:386-96
35. Masui K, Kira M, Kazama T, Hagihira S, Mortier EP, Struys MM. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate. Anesthesiology 2009;111:805-17
36. Rigouzzo A, Servin F, Constant I. Pharmacokineticpharmacodynamic modeling of propofol in children. Anesthesiology 2010;113:343-52
37. Lloret Linares C, Declèves X, Oppert JM, Basdevant A, Clement K, Bardin C, Scherrmann JM, Lepine JP, Bergmann JF, Mouly S. Pharmacology of morphine in obese patients: Clinical implications. Clin Pharmacokinet 2009;48:635-51
38. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumié A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clément K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgeryinduced weight loss. Diabetes 2005;54:2277-86
39. Ramzan I, Wong BK, Corcoran GB. Pain sensitivity in dietaryinduced obese rats. Physiol Behav 1993;54:433-5
40. McKendall MJ, Haier RJ. Pain sensitivity and obesity. Psychiatry Res 1983;8:119-25
41. Cortínez LI, Gambús P, Trocóniz IF, Echevarría G, Muñoz HR. Obesity does not influence the onset and offset of sevoflurane effect as measured by the hysteresis between sevoflurane concentration and bispectral index. Anesth Analg 2011;113:70-6
42. Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: Response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology 2003;99:347-59
43. Kern SE, Xie G, White JL, Egan TD. A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers. Anesthesiology 2004;100:1373-81
44. Bouillon TW, Bruhn J, Radulescu L, Andresen C, Shafer TJ, Cohane C, Shafer SL. Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy. Anesthesiology 2004;100:1353-72
45. Kortelainen J, Koskinen M, Mustola S, Seppänen T. Effects of remifentanil on the spectrum and quantitative parameters of electroencephalogram in propofol anesthesia. Anesthesiology 2009;111:574-83 Tecnológico